UNMASKING CARDIOVASCULAR RISK IN SUBCLINICAL HYPOTHYROIDISM: THE INTERPLAY OF DYSLIPIDEMIA AND OXIDATIVE STRESS
International Journal of Drug Delivery Technology · 08.07.2026 · 16 (63s)
DOI: 10.25258/ijddt.16.63s.25 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 08.07.2026. Verfasst von Imran Yusuf und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Subclinical hypothyroidism (SCH) is an endocrine disorder characterized by elevated thyroidstimulating hormone (TSH) levels and normal concentration of circulating thyroid hormone. Emerging evidence suggests that SCH may contribute to dyslipidemia, impaired glucose metabolism, oxidative stress, and increased cardiovascular risk. The present study aimed to evaluate alterations in the extended lipid profile, sugar profile, and total antioxidant capacity (TAC) in patients with SCH and to investigate their association with serum TSH levels. Methodology: In this study, we have considered a total of 410 subjects, consisting of 205 controls and 205 cases of subclinical hypothyroidism. This cross-sectional study included adults aged 18–60 years diagnosed with SCH and age- and sex-matched euthyroid healthy controls. Fasting blood samples were collected for estimation of thyroid profile, extended lipid profile [total cholesterol (TC), triglycerides (TG), HDL-C, LDL-C, VLDL-C, non-HDL-C, apolipoprotein A1 (ApoA1), apolipoprotein B (ApoB), ApoB/ApoA1 ratio, and atherogenic indices], sugar profile [fasting blood sugar (FBS), postprandial blood sugar (PPBS), and HbA1c], and total antioxidant capacity. Statistical analysis was performed to compare biochemical parameters between groups and to assess correlations between TSH levels and study variables by using the Statistical Package for the Social Sciences (SPSS) software version 29.
Results
Patients with SCH demonstrated significantly higher levels of TC, TG, LDL-C, non-HDL-C, ApoB, ApoB/ApoA1 ratio, and atherogenic indices compared with controls, while HDL-C and ApoA1 levels were significantly lower. The SCH group also exhibited significantly elevated FBS, PPBS, and HbA1c levels, indicating impaired glucose metabolism. The total antioxidant capacity was significantly reduced among SCH subjects, indicating increased oxidative stress. Serum TSH levels showed significant positive correlations with atherogenic lipid parameters and glycemic indices and a significant negative correlation with TAC.
Conclusion
Subclinical hypothyroidism is associated with adverse alterations in lipid metabolism, impaired glycemic status, and reduced antioxidant defense, all of which may contribute to increased cardiovascular risk. Assessment of extended lipid parameters, sugar profile, and total antioxidant capacity may provide valuable insights for early identification and management of cardiovascular risk in patients with SCH
Zitieren
APA
Yusuf, I., Aggarwal, J., Khan, M. N., & Batra, J. (2026). UNMASKING CARDIOVASCULAR RISK IN SUBCLINICAL HYPOTHYROIDISM: THE INTERPLAY OF DYSLIPIDEMIA AND OXIDATIVE STRESS. International Journal of Drug Delivery Technology, 16(63s). https://doi.org/10.25258/ijddt.16.63s.25
Vancouver
Yusuf I, Aggarwal J, Khan MN, Batra J. UNMASKING CARDIOVASCULAR RISK IN SUBCLINICAL HYPOTHYROIDISM: THE INTERPLAY OF DYSLIPIDEMIA AND OXIDATIVE STRESS. International Journal of Drug Delivery Technology. 2026;16(63s). doi:10.25258/ijddt.16.63s.25
BibTeX
@article{Yusuf2026,
author = {Yusuf, Imran and Aggarwal, Juhi and Khan, M. N. and Batra, Jyoti},
title = {UNMASKING CARDIOVASCULAR RISK IN SUBCLINICAL HYPOTHYROIDISM: THE INTERPLAY OF DYSLIPIDEMIA AND OXIDATIVE STRESS},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {63s},
doi = {10.25258/ijddt.16.63s.25}
}
EUVIMED